WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1992000755) IMMUNE SYSTEM STABILIZERS FOR PREVENTION AND THERAPY OF DISORDERS ASSOCIATED WITH IMMUNE SYSTEM DYSFUNCTION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1992/000755    International Application No.:    PCT/CA1991/000240
Publication Date: 23.01.1992 International Filing Date: 11.07.1991
Chapter 2 Demand Filed:    01.02.1992    
IPC:
C07K 14/16 (2006.01), C07K 14/74 (2006.01), C07K 16/28 (2006.01)
Applicants: HOFFMANN, Geoffrey, W. [AU/CA]; (CA).
KION, Tracy, A. [CA/CA]; (CA).
WELDER, Clayton, A. [CA/CA]; (CA)
Inventors: HOFFMANN, Geoffrey, W.; (CA).
KION, Tracy, A.; (CA).
WELDER, Clayton, A.; (CA)
Agent: ADE & COMPANY; 1700-360 Main Street, Winnipeg, Manitoba R3C 3Z3 (CA)
Priority Data:
551,262 11.07.1990 US
629,331 18.12.1990 US
Title (EN) IMMUNE SYSTEM STABILIZERS FOR PREVENTION AND THERAPY OF DISORDERS ASSOCIATED WITH IMMUNE SYSTEM DYSFUNCTION
(FR) STABILISATEURS DU SYSTEME IMMUNITAIRE SERVANT A LA PREVENTION ET A LA THERAPIE DE TROUBLES ASSOCIES AU DYSFONCTIONNEMENT DU SYSTEME IMMUNITAIRE
Abstract: front page image
(EN)Substances that bind to alloimmune-immunogen-absorbed (AIA) sera have been found to be effective in the prevention and therapy of autoimmune disease. It is conjectured that the mechanism involves indirect stimulation of suppressor T cells resulting in stabilization of the immune system. The administration of such substances is expected to be useful in the prevention and treatment of diseases that involve a failure of the immune system to distinguish adequately between self and nonself, including autoimmune diseases and immunodeficiency diseases.
(FR)Certaines substances se liant aux sérums alloimmuns immunogènes absorbés (AIA) se sont avérées efficaces dans la prévention et la thérapie de troubles auto-immuns. On pense que le mécanisme implique une stimulation indirecte des lymphocytes T suppresseurs, ce qui provoque une stabilisation du système immunitaire. L'administration de ces substances est supposée être efficace dans la prévention et le traitement de troubles impliquant une défaillance du système notamment les troubles autoimmuns et immunodéficitaires.
Designated States: AT, AU, BB, BG, BR, CA, CH, CS, DE, DK, ES, FI, GB, HU, JP, KP, KR, LK, LU, MC, MG, MN, MW, NL, NO, PL, RO, SD, SE, SU.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)